一种类型的胺酸酸激酶i5抑制YAP1信号传递
Chinmoy Ghosh1, Ruchi Kakar1, Matthew Bavuso1
1Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, School of Dentistry, Virginia Commonwealth University, Richmond, Virginia, USA.
The Journal of biological chemistry
|August 10, 2025
概括
I型胺酸酸盐酶i5 (PIPKIγi5) 通过产生PI4,5P2来抑制YES相关蛋白1 (YAP1) 信号,从而使YAP1留在细胞质中. 减少PIPKIγi5增强了YAP1的信号传递和瘤的形成.
科学领域:
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
- 在瘤学瘤学.
背景情况:
- 河马/Yes相关蛋白 (YAP) 信号通路失调与癌症等疾病有关.
- 希波/YAP信号传输的分子机制和调节器尚未完全理解.
- 识别新型调节剂对于理解疾病的发病过程至关重要.
研究的目的:
- 为了识别Hippo/YAP信号通路的新型调节者.
- 阐明I型胺酸酸盐激酶i5 (PIPKIγi5) 在YAP1信号传递中的作用.
- 研究PIPKIγi5对癌细胞干细胞的影响.
主要方法:
- 研究了PIPKIγi5和YAP1.1之间的相互作用.
- 评估了PIPKIγi5激酶活性对YAP1核转位的影响.
- 利用头部和部状细胞癌模型来研究瘤球的形成.
主要成果:
- PIPKIγi5直接与YAP1相互作用,防止其核转位,并抑制YAP1介导的转录.
- 在这种抑制中,PIPKIγi5的激酶活性产生酸丁酸-4,5-双酸盐 (PI4,5P2) 是必不可少的.
- PI4,5P2促进了YAP1与14-3-3蛋白的相互作用,使YAP1留在细胞质中.
- 耗尽PIPKIγi5增强了YAP1的信号传递,并促进了头部和部状细胞癌中瘤球的形成.
结论:
- PIPKIγi5通过PI4,5P2的产生,作为YAP1介导信号的抑制剂.
- 这种PI4,5P2-调节的信号连接提供了对Hippo/YAP信号的特定控制.
- 皮普基γi5是YAP1功能的关键调节者,对癌症干细胞性有影响.
相关概念视频
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
Amplifying Signals via Enzymatic Cascade
8.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.7K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Phosphoinositides and PIPs
8.7K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.7K


